BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31652125)

  • 1. The "question-mark" MR anatomy of the cervico-thoracic ganglia complex: can it help to avoid mistaking it for a malignant lesion on 68Ga-PSMA-11 PET/MR?
    Bialek EJ; Malkowski B
    Radiol Oncol; 2019 Oct; 53(4):407-414. PubMed ID: 31652125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the level of diffusion restriction in celiac and cervico-thoracic sympathetic ganglia helpful in their proper recognition on PSMA ligand PET/MR?
    Bialek EJ; Malkowski B
    Nuklearmedizin; 2020 Aug; 59(4):300-307. PubMed ID: 32005043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiac ganglia: can they be misinterpreted on multimodal 68Ga-PSMA-11 PET/MR?
    Bialek EJ; Malkowski B
    Nucl Med Commun; 2019 Feb; 40(2):175-184. PubMed ID: 30480555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are superior cervical sympathetic ganglia avid on whole body 68Ga-PSMA-11 PET/magnetic resonance?: a comprehensive morphologic and molecular assessment in patients with prostate cancer.
    Bialek EJ; Malkowski B
    Nucl Med Commun; 2019 Nov; 40(11):1105-1111. PubMed ID: 31469805
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Rischpler C; Beck TI; Okamoto S; Schlitter AM; Knorr K; Schwaiger M; Gschwend J; Maurer T; Meyer PT; Eiber M
    J Nucl Med; 2018 Sep; 59(9):1406-1411. PubMed ID: 29371407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake in sympathetic ganglia on
    Kanthan GL; Hsiao E; Vu D; Schembri GP
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):732-738. PubMed ID: 28623872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reconstruction algorithm used for [
    Krohn T; Birmes A; Winz OH; Drude NI; Mottaghy FM; Behrendt FF; Verburg FA
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):662-669. PubMed ID: 27900518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
    Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
    J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation.
    Rahman LA; Rutagengwa D; Lin P; Lin M; Yap J; Lai K; Mancuso P; Rathore P; Haghighi K; Gassner P; Wong LH; Lalak N
    Cancer Imaging; 2019 Dec; 19(1):86. PubMed ID: 31829288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Body Integrated [
    Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
    Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of
    Schwenck J; Rempp H; Reischl G; Kruck S; Stenzl A; Nikolaou K; Pfannenberg C; la Fougère C
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):92-101. PubMed ID: 27557844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
    Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
    Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
    BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Para-aortal Ganglion Mimicking a Lymph Node Metastases on 68Ga-PSMA PET/CT.
    Schweighofer Zwink G; Rendl G; Schmeller N; Pirich C
    Clin Nucl Med; 2020 Nov; 45(11):883-885. PubMed ID: 32804765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer.
    Pyka T; Weirich G; Einspieler I; Maurer T; Theisen J; Hatzichristodoulou G; Schwamborn K; Schwaiger M; Eiber M
    J Nucl Med; 2016 Mar; 57(3):367-71. PubMed ID: 26585062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of early imaging with
    Özülker F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):100-105. PubMed ID: 30514659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers.
    Calabria F; Pichler R; Leporace M; Wolfsgruber J; Coscarelli P; Dunzinger A; Schillaci O; Cascini GL; Bagnato A
    Curr Radiopharm; 2019; 12(3):238-246. PubMed ID: 31113354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.